Dr. William Cody Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 Wilson Creek Rd, Lawrenceburg, IN 47025 Phone: 812-537-8138 |
Lisa Jane Folop Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 880 W Eads Pkwy, Lawrenceburg, IN 47025 Phone: 812-532-7360 Fax: 812-532-7361 |
Dr. Kevin E Burns, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 600 Wilson Creek Rd, Lawrenceburg, IN 47025 Phone: 812-537-8183 Fax: 812-537-2533 |
Denise Rollins, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 W Eads Pkwy, Lawrenceburg, IN 47025 Phone: 812-537-5711 |
Scott Carpenter Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 880 W Eads Pkwy, Lawrenceburg, IN 47025 Phone: 812-537-5280 |
Amy Barber, RPH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 880 W Eads Pkwy, Lawrenceburg, IN 47025 Phone: 812-532-7360 |
Mr. James Arthur Geis Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 W Eads Pkwy, Lawrenceburg, IN 47025 Phone: 812-539-3492 |
News Archive
Male homosexuality doesn't make complete sense from an evolutionary point of view. It appears that the trait is heritable, but because homosexual men are much less likely to produce offspring than heterosexual men, shouldn't the genes for this trait have been extinguished long ago? What value could this sexual orientation have, that it has persisted for eons even without any discernible reproductive advantage?
Full-time employment is a major reason that able-bodied adults would have incomes above 133 percent of the federal poverty level. If carried out, this expansion is expected to reduce full-time employment among able-bodied adults, because they would no longer need to be employed full time to obtain health insurance.
Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascepion Pharmaceuticals, Inc., a privately-held, biopharmaceutical company dedicated to the discovery and development of breakthrough small molecule drugs for the treatment of oncology and related diseases, have entered into an exclusive worldwide license agreement concerning the development and commercialization of ASP-08126 (called Debio 1144 by Debiopharm) a multikinase inhibitor currently in pre-clinical development.
The sleep patterns of patients in the intensive care unit are so superficial that they barely spend any time in the restorative stages of sleep that aid in healing, UT Southwestern Medical Center physicians have found.
› Verified 2 days ago